ELIZABETH MACKIE: Open Payments
NPI 1679992234 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$45,386 in 222 payments from 18 companies in 2025. Trend: 2023 $21,046 · 2024 $26,552 · 2025 $45,386
Speaker / faculty: $34,200Travel & lodging: $6,247Food & beverage: $4,197Consulting: $675Education: $66
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 63 | $26,107 |
| ABBVIE INC. | 65 | $17,335 |
| Janssen Biotech, Inc. | 15 | $364 |
| PFIZER INC. | 24 | $309 |
| Arcutis Biotherapeutics, Inc. | 10 | $266 |
| GENZYME CORPORATION | 8 | $244 |
| Organon LLC | 15 | $156 |
| UCB, Inc. | 3 | $146 |
| Regeneron Healthcare Solutions, Inc. | 4 | $121 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $94 |
Products named: EBGLYSS, RINVOQ, SKYRIZI, BOTOX, TREMFYA, CIBINQO, DUPIXENT, Zoryve.
Industry payments across TX — which companies pay providers there.
